Autopsy report · NCT06590571

The Study for Evaluate of Satety and Dfficacy of Hemostatic Device

“The company stopped manufacturing the product”

The sponsor’s own words in the registry.

Life of this trial

• Registered 5 years 8 months after it had already started.
• Ran for about 3 years 1 month before it stopped.
• 227 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Pusan National University Yangsan Hospital

Sponsor type

University, hospital or other

Conditions

Coronary Artery Disease

Interventions

TRAcelet™; Gauze pad

Participants

227

Sites

1

Countries

South Korea

Trials that died the same way

• Active Surveillance Post-Approval Atudy of the Stelkast Surpass Acetabular System
  “Product is no longer being manufactured and marketed.” (74% match in meaning)
• A Pilot, Dose Escalating Study on VLX103 in Moderate Alcoholic Steatohepatitis
  “Drug manufacturer ceased operations” (71% match in meaning)
• Oblimersen Sodium & Combination Chemotherapy in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma
  “Manufacturer is no longer making the drug.” (68% match in meaning)
• Safety and Pharmacokinetics of UV-4B Solution Administered Orally as Multiple Ascending Doses to Healthy Subjects
  “Product development halted for business reasons.” (68% match in meaning)
• Radiographic Analysis Using PureGen Versus Autologous Bone in Posterolateral Fusion (PLF)
  “Product no longer on the market” (65% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.